Validity of sheet-type portable monitoring device for screening obstructive sleep apnea syndrome |
| |
Authors: | Mina Kobayashi Kazuyoshi Namba Satoru Tsuiki Masaki Nakamura Masamichi Hayashi Yuuki Mieno Hiromi Imizu Shiho Fujita Atsushi Yoshikawa Hiroki Sakakibara Yuichi Inoue |
| |
Institution: | 1. Neuropsychiatric Research Institute, Japan Somnology Center, 1-24-10, Yoyogi, Shibuya-ku, Tokyo, 151-0053, Japan 2. Yoyogi Sleep Disorder Center, 1-24-10, Yoyogi, Shibuya-ku, Tokyo, 151-0053, Japan 3. Department of Somnology, Tokyo Medical University, 6-7-1, Nishishinjyuku, Shinjyuku-ku, Tokyo, 160-0023, Japan 4. Department of Internal Medicine, Division of Respiratory Medicine & Clinical Allergy, Fujita Health University School of Medicine, 1-98, Dengakubo, Kutsukake-cho, Toyoake-shi, Aichi, 470-1192, Japan 5. Department of Laboratory Medicine, Fujita Health University Hospital, 1-98, Dengakubo, Kutsukake-cho, Toyoake-shi, Aichi, 470-1192, Japan
|
| |
Abstract: | Purpose The SD-101 is a non-restrictive sheet-like medical device that measures sleep-disordered breathing using pressure sensors that can detect the gravitational alterations in the body that accompany respiratory movement. One report has described that the screening specificity of the SD-101 for mild to moderate obstructive sleep apnea syndrome (OSAS) is relatively low. The present study examines whether the accuracy of the SD-101 for OSAS screening is improved by simultaneously measuring percutaneous oxygen saturation (SpO2). Methods Sixty consecutive individuals with suspected OSAS consented to undergo overnight polysomnography (PSG) together with simultaneous measurements of SD-101 and SpO2 at our laboratory. Results The apnea–hypopnea index (AHI) determined from PSG and the respiratory disturbance index determined from SD-101 measurements significantly correlated (SD-101 alone: r?=?0.871, p?<?0.0001; SD-101 with SpO2: r?=?0.965, p?<?0.0001). Bland–Altman plots showed a smaller dispersion for the SD-101 with SpO2 than for the SD-101 alone. The SD-101 with SpO2 detected an AHI of >15 on PSG with a sensitivity and specificity of 96.9 and 90.5 % compared with 87.5 and of 85.7 %, respectively, of the SD-101 alone. Conclusions Simultaneously measuring SpO2 improved the accuracy of the SD-101 for OSAS screening. Furthermore, this modality appears to offer high sensitivity and specificity for detecting even moderately severe OSAS. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|